Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (8)
Prostate-specific membrane antigen (PSMA) (4)
PET/CT (3)
Prostate carcinoma (3)
68Ga-PSMA (2)
Breast cancer (2)
Cervical cancer (2)
Computed tomography (CT) (2)
Hypoxia (2)
Immunohistochemistry (2)
SDG-03: Good health and well-being (2)
Tuberculosis (TB) (2)
18F-FDG (1)
225Ac-PSMA-617 (1)
68Ga-citrate (1)
68Ga-Nitroimidazole (1)
[68Ga]Ga-FAPI PET/CT (1)
Behandlung (1)
Benign vs. malignant (1)
Bins (1)
Bioassay (1)
Biomaterials (1)
Black South-African (BSAs) (1)
Blood–brain barrier (BBB) (1)
Bone SPECT-CT (1)
Characterization (1)
Chelation (1)
Chemical analysis (1)
Chemical modification (1)
Chromatography (1)
Colorectal cancer (1)
Computerized tomography (CT) (1)
Computerized tomography' (CT) (1)
Cryptic peptides (1)
Dichroism (1)
Drug products (1)
FAPI tumor volume (FAPI-TV) (1)
FDG PET/CT (1)
FDG-PET (1)
FDG-PET imaging (1)
Fludeoxyglucose (FDG) (1)
Fluorine-18-Fluorodeoxyglucose (FDG) (1)
Fluorodeoxyglucose-positron emission tomography (FDG PET) (1)
Functional characterization (1)
Gastro-intestinal cancer (1)
GHR bioassay (1)
Growth hormone receptor (GHR) (1)
Highly active antiretroviral therapy (HAART) (1)
HIV infection (1)
Human growth hormone (1)
Hypoxia inducible factor-1 (HIF-1) (1)
Hypoxia-inducible factor-1alpha (HIF-1) (1)
Hypoxic tumor volume (HTV) (1)
Immunohistochemistry (IHC) (1)
Inherent complexity (1)
Intra-tumoral heterogeneity (1)
Isomers (1)
Lipodystrophy (1)
Logistic binomial regression (1)
Loosening (1)
Lumbar fusion (1)
Lung lesions (1)
Mass spectrometry (1)
Medical imaging (1)
Metabolic tumor volume (MTV) (1)
Metastatic prostate carcinoma (1)
Multiple substitutions (1)
Native mass spectrometries (1)
Native MS (1)
Non-prostate carcinoma (1)
Ovarian cancer (1)
Overall survival (OS) (1)
Patient management (1)
Patienten management (1)
Pedicle screws (1)
Physico-chemical characterization (1)
Positron emission tomography/computed tomography (PET/CT) (1)
Primary prostate carcinoma (PPC) (1)
Principal component analysis (PCA) (1)
Progression-free survival (PFS) (1)